Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
4.0
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.28
1.93
NAV
₹276.65
₹426.51
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1106.71 Cr
₹4076.67 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
8.27%
8.09%
3 Year
25.23%
25.69%
5 Year
14.88%
17.02%
Equity
98.21%
98.53%
Cash
1.79%
1.39%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.42% |
Ajanta Pharma Ltd. | 7.04% |
Lupin Ltd. | 5.79% |
Glenmark Pharmaceuticals Ltd. | 4.25% |
Apollo Hospitals Enterprise Ltd. | 3.75% |
Gland Pharma Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.52% |
Dr. Reddy's Laboratories Ltd. | 3.48% |
Alkem Laboratories Ltd. | 3.47% |
Fortis Healthcare Ltd. | 2.98% |
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999
